Benitec Biopharma Inc.

BNTC | NASDAQ

Price Alert Chart Builder DCF Calculator

$10.98

+$0.10 (+0.92%)

Sep 22, 2026, 9:44 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $373.77M

Enterprise Value $194.56M

Beta 0.27

Average Volume 125.18K

Shares Outstanding (Diluted) 46.56M

Shares Change YoY 28.58%

Institutional Ownership 65.77%

Exchange NASDAQ

ISIN US08205P2092

Price Performance

Price Change 1M -18.3%

Price Change 3M -15.5%

Price Change 6M 0.4%

Price Change YTD -13.6%

Price Change 1Y -19.5%

Price Change 3Y 256.7%

Price Change 5Y -83.5%

1M CAGR (ann.) -20.2%

1Y CAGR (ann.) -22.2%

5Y CAGR (ann.) -30.3%

All-Time CAGR -40.2%

Valuation

PE Ratio -11.10

Forward PE N/A

PEG Ratio -0.21

Forward PEG -0.45

PS Ratio N/A

Forward PS 17.10

PB Ratio 2.11

P/FCF Ratio -21.88

P/Adj. FCF Ratio -10.41

P/OCF Ratio -30.22

EV/Sales N/A

EV/EBIT -3.80

EV/EBITDA -3.84

EV/FCF -11.39

Earnings Yield -9.0%

FCF Yield -4.6%

Adj. FCF Yield -9.6%

Financial Health

Net Cash $179.71M

Total Debt $762K

Cash & Short-Term Investments $179.97M

Total Assets $182.62M

Current Ratio 34.00

Quick Ratio 34.00

Debt / Equity Ratio 0.00

Debt / EBITDA -0.02

Debt / FCF -0.04

OCF / Debt -22.28

Interest Coverage 21.32

Altman Z-Score 38.11

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -110.1%

Returns

Return on Assets -24.9%

Return on Equity -28.4%

Return on Invested Capital -28.8%

Return on Capital Employed -28.9%

Return on Tangible Assets -24.9%

Historical Growth (CAGR)

Revenue CAGR 3Y 1.6%

Revenue CAGR 5Y 24.0%

Revenue CAGR 10Y -29.1%

EPS CAGR 3Y 30.9%

EPS CAGR 5Y 46.5%

EPS CAGR 10Y 29.8%

FCF CAGR 3Y 6.3%

FCF CAGR 5Y -8.3%

FCF CAGR 10Y -13.5%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 8

EPS Growth Next 3Y -13.6%

Revenue Growth Next 3Y N/A

Earnings Date Nov 12, 2026

EPS Estimate (next Q) -$0.27

EPS Growth Est (next Q) 22.1%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $21

Price Target Upside 93.0%

Cash Flow

Operating Cash Flow $-16.98M

Free Cash Flow $-17.08M

Adj. Free Cash Flow $-35.9M

FCF Per Share -$0.37

OCF Per Share -$0.36

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-481K

Operating Income $-51.19M

EBITDA $-50.71M

Net Income $-45.55M

EPS (Diluted) -$0.98

Revenue / Employee N/A

Profit / Employee $-2.4M

Employees 19